MAD2 Activates IGF1R/PI3K/AKT Pathway and Promotes Cholangiocarcinoma Progression by Interfering USP44/LIMA1 Complex

By
Noshin Noorjahan
-
0
283
Investigators found up-regulated mitotic arrest deficient 2 (MAD2) facilitated cholangiocarcinoma progression and induced lymphatic metastasis dependent on USP44/LIMA1/PI3K/AKT pathway.
[Oncogene]
Abstract